Objectives People with spondyloarthritis (SpA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) have identifi ed the importance of understanding how their disease and its treatment impacts on their social roles. This requires a reliable and valid standardised measure, and this study evaluates these measurement properties of the Social Role Participation Questionnaire (SRPQ). Methods 109 participants (44 with AS, 65 with PsA) completed questionnaires on demographics, participation measures (SRPQ, Keele Assessment of Participation (KAP), Late Life Disability Instrument (LLDI)), disease severity (physician global) and activity (pain, fatigue, Bath Ankylosing Spondylitis Disease Activity Index), psychological measures (depressive symptoms (Hospital Anxiety and Depression Scale), Illness Intrusiveness)) and function (Health Assessment Questionnaire, Bath Ankylosing Spondylitis Functional Index). After testing scaling properties, test-retest reliability of the SRPQ was evaluated using intraclass correlation coeffi cients (ICC) and hypotheses of construct validity were evaluated using correlation coeffi cients. Results Patients with AS had a mean age of 40 years and 65% were male, whereas patients with PsA had a mean age of 53 years and 63% were male. Although there were some differences between AS and PsA participants in their social role participation, scaling properties were good for both groups. ICCs were >0.90 for the satisfaction subscales of the SRPQ. For construct validity, SRPQ satisfaction subscales were moderately correlated with the KAP and LLDI (0.64-0.78), and less satisfaction was associated with higher disease severity and activity, more depressive symptoms, more illness intrusiveness and more disability (coeffi cients −0.67 to −0.88). Conclusion Social role participation is an important concept for people with SpA, and the SRPQ is a reliable and valid measure for use with people with AS and PsA.
INTRODUCTION
The signs and symptoms of spondyloarthritis (SpA)-specifi cally ankylosing spondylitis (AS) and psoriatic arthritis (PsA)-frequently occur in the third to fi fth decades of life 1 when family, employment, social and leisure roles are prominent. Despite the saliency of these social roles and their relevance to health-related qualtiy of life (HRQoL), 2 a limited literature describes individual aspects of role participation (eg, employment) in peaople with SpA. 3 -6 Role participation is important given that advances in the treatment of SpA with disease-modifying drugs (DMARDs) and biological agents have shifted the treatment paradigm from managing symptoms alone to slowing and potentially averting disease progression. 7 -10 Yet longstanding disability that negatively impacts HRQoL continues for many individuals. 11 12 As such, evaluating the impact of interventions such as DMARDs and biological agents in maintaining or improving social role participation is critical to understanding their benefi t. To date, no standardised measure has been used to evaluate social role participation in a comprehensive manner. 2 This study addresses this gap, evaluating the measurement properties (content validity, reliability and construct validity) of the Social Role Participation Questionnaire (SRPQ) in people with SpA to determine if the questionnaire has suitable properties for use in future research studies to measure the impact of SpA on participation.
The World Health Organization's International Classifi cation of Functioning, Disability and Health (ICF) defi nes participation as involvement in life situations. 13 Such life situations or roles are broad patterns of purposeful behaviour at the level of societal involvement. 14 They are expected, taught and encouraged within sociocultural contexts and are often undertaken because of a sense of personal value or necessity. 15 -17 They include involvement in close relationships (eg, parenting), being a student or employee and aspects of a person's identity related to social and leisure activities (eg, volunteer). These domains refl ect broader life situations than those evaluated by activities of daily living. 14 18 Based on work using the ICF framework, people with AS reported mild or greater restriction in the domains of recreation and leisure, community life, remunerative employment, intimate relationships, informal social relationships, basic interpersonal interactions, family relationships, higher education, complex interpersonal interactions, formal relationships and assisting others. 19 Similarly, people with PsA reported reduced ability to fulfi l personal roles, limitations in their social life and work. 20 Taylor et al similarly found that, while people with PsA experienced diffi culties in many areas in the ICF domains of Activities and Participation, these domains mapped poorly to existing 'participation' and HRQoL measures that include subscales related to social functioning. 21 The fi ndings of Taylor et al confi rmed previous work by Stamm et al . 22 We chose to evaluate the SRPQ as it was conceptualised to include the domains of the ICF framework based on pilot work in people with osteoarthritis, work, psychosocial role research, existing participation measures and published arthritis studies. 17 Additionally, in contrast to many existing standardised measures evaluating 'participation' that have focused on diffi culty with or the frequency of performing specifi c tasks required for participation, 14 18 23 the SRPQ evaluates the importance of the role to the person and the perceived satisfaction with performing the various roles in the way desired and with the time spent in the role. 17 
METHODS Participants
People with SpA were recruited from subspecialty clinics at the Toronto Western Hospital, Toronto, Canada. Participants ranged from those newly diagnosed to those with active or stable disease. Eligibility included age ≥18 years, ability to complete English language questionnaires and consent to participate. Exclusion criteria included other musculoskeletal diseases (eg, fi bromyalgia, a new fracture) or neurological diseases (eg, multiple sclerosis, stroke, Parkinson's disease) that might have an impact on participation. Of the 126 subjects eligible to participate, 109 consented and returned questionnaires (44 AS and 65 PsA). Patients with AS were younger, had shorter disease duration and were more likely to be engaged in educational pursuits ( table 1 ).
Procedures
All participants completed demographic information (age, sex, living status, work status and current educational pursuits) and reported disease duration in addition to completing a battery of questionnaires described below.
To ensure content validity, understanding and clarity of the items, cognitive debriefi ng was conducted for the SRPQ with the fi rst 15 participants. They also identifi ed omissions of important roles and irrelevant content.
For test-retest reliability, a subsample completed the SRPQ 2-3 weeks after completing the fi rst questionnaire. To ensure stability in the test period, respondents indicated if they felt their condition had changed in the interval.
Measures

Participation
The SRPQ includes 12 social role domains. 17 Participants rated the importance of the role from 1 (not at all important) to 5 (extremely important) and their satisfaction each with time spent and their ability to participate in that role in the way they wanted (ie, role performance) from 1 (not at all satisfi ed) to 5 (extremely satisfi ed). If a respondent did not participate in a role they were instructed to choose 'not applicable' and did not provide an importance or satisfaction rating for that item. The mean score for each subscale was calculated providing at least nine of the 12 domains were answered.
The Keele Assessment of Participation (KAP) measures the occurrence of participation restriction in population samples. 24 It includes 11 items across three areas (mobility, domestic life and major life), with responses on a 5-point scale (all the time to none of the time). We created a summed score based on achieving suffi cient internal consistency (Cronbach's α 25 for the 11 items was 0.81 and 0.89 for AS and PsA, respectively).
The Late Life Disability Instrument (LLDI) evaluates frequency and limitations in performing life tasks. 26 Role domains and activities within each subscale are scored from 1 to 5 with higher scores indicating more frequent involvement and less limitation. Summed scores were calculated for each subscale.
Disease severity
For patients with PsA, the physician provided a global assessment of disease activity on a scale of 0-10 where higher scores indicated more severe disease.
Disease activity
Participants with AS completed the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) which includes fatigue, spinal and peripheral joint pain, localised tenderness and severity and persistence of morning stiffness. 27 Responses ranging from 0 to 10 were averaged, with higher scores indicating greater severity.
Participants with AS completed a numerical pain rating scale related to their back pain and those with PsA rated their current pain severity, both on a scale of 0-10 where higher scores indicated more pain.
All participants completed the Fatigue Severity Scale, a measure of general fatigue that includes nine items asking about the severity and characteristics of fatigue in the past week. 28 Response options range from 0 (not at all) to 10 (yes completely), and a summary score was computed based on the average of the item scores. 29 
Psychological
Depressive symptoms were evaluated using the 7-item subscale of the Hospital Anxiety and Depression Scale (HADS). 30 All items are scored on a 4-point scale from 0 to 3, and higher scores indicate more depressive symptoms.
The 13-item Illness Intrusiveness Scale measures illnessinduced disruptions to activities, well-being and daily life. 31 32 Response options range from not very much (1) to very much (7) and not applicable (99). The summary score is the sum of the individual items.
All participants completed the HADS and Illness Intrusiveness Scale.
Function
All completed the Health Assessment Questionnaire (HAQ), commonly used to report disability from arthritis. Participants respond on a scale from 0 (without any diffi culty) to 3 (unable to do). 33 34 The highest item score determines the value for each category and use of an aid or assistance results in a score increase. The average score across categories was calculated.
The Bath Ankylosing Spondylitis Functional Index has 10 questions asking about ability to do various activities in the past week. The scoring is 0-10, as in the BASDAI. 35 
Analysis of data
Descriptive statistics were calculated for participant characteristics. Means and SDs were calculated for the individual items and subscales of the SRPQ. Scalability was evaluated by inter-item correlation coeffi cients where the desired range was 0.30-0.80 to represent suffi cient item associations without redundancy. Cronbach's α was calculated as a measure of homogeneity 25 where the desired value was ≥0.80.
Test-retest was calculated using the intraclass correlation coeffi cient (ICC) version 2,1. 36 37 A value of 0.90 was considered suffi cient for individuals with at least 0.80 for groups. 38 The standard error of measurement (SEM) based on the test-retest reliability coeffi cient and the minimal detectable change at the 95% confi dence level (MDC 95 ) 39 40 were calculated.
A priori hypotheses for testing construct validity were evaluated by correlational analyses using Pearson correlation (r). Correlations <0.4 were considered weak, 0.4-0.70 were moderate and >0.70 were considered strong. We hypothesised that the SRPQ satisfaction subscales would be moderately positively associated with measures of participation with content more focused on requisite tasks for participation. We also hypothesised that there would be a moderate inverse association between satisfaction subscales and disease severity, disease activity, depressive symptoms and illness intrusiveness, and function.
Furthermore, we anticipated that the SRPQ importance rating would be more highly correlated with satisfaction with time spent and role performance in older than younger individuals based on research on social networks, life course and successful ageing. This research suggests that older individuals voluntarily shrink their social network to include familiar and emotionally close partners whereas younger adults are more likely to choose novel social partners and activities. 41 42 As such, given the stage of life course, younger individuals would rate roles as more important but would experience less satisfaction with participation given the potential restrictions imparted by the morbidity of their disease.
Finally, we hypothesised that those who were not working due to their disease would report less satisfaction. This hypothesis was evaluated with the Wilcoxon test.
RESULTS
Content validity and scaling of the SRPQ
Cognitive debriefi ng of the SRPQ did not identify any items that were missing or unimportant and respondents thought the questionnaire was easily understood.
The range of response options was used for importance and the satisfaction importance of the different domains was similar for AS and PsA, with mean importance ranging from 1.4 to 3.6. Mean satisfaction ratings ranged from 1.3 to 3.3 and were similar for both time spent and role performance for both AS and PsA (online supplementary table). The inter-item correlations ranged from 0.09 to 0.75 for importance and from 0.36 to 0.89 for satisfaction with time spent and role performance for both AS and PsA ( table 2 ). Cronbach's α for importance was 0.70 for patients with AS and 0.82 for those with PsA, compared with ≥0.93 for the satisfaction subscales.
Reliability of the SRPQ
Fifty-two participants (13 with AS, 39 with PsA) participated in test-retest reliability testing and reported no change over the 2-week test period. The ICC for importance for PsA was suffi cient for groups whereas it was suffi cient for groups and individuals for AS ( table 2 ). The satisfaction with time spent and role performance subscales had ICCs in excess of 0.90 for both AS and PsA participants, indicating reliability for both groups and individuals. The MDC 95 ranged from 0.43 to 0.86 depending on the construct, with the values tending to be slightly larger for those with PsA.
Construct validity
Overall our a priori hypotheses were supported, demonstrating construct validity of the SRPQ ( table 3 ) . The SRPQ satisfaction subscales were moderately correlated (range 0.64-0.78) with other measures of participation (KAP and LLDI). For participants with AS the correlations of the SRPQ satisfaction subscales with the LLDI limitations subscale were slightly higher than anticipated at 0.76 and 0.78.
Disease severity, disease activity, psychological and function measures had moderate associations with the satisfaction subscales of the SRPQ, with a few exceptions ( table 3 ). Fatigue had larger associations with satisfaction ranging from −0.72 to −0.80 for both AS and PsA, and illness intrusiveness had high correlations with satisfaction for AS (−0.88). Total back pain had small and nonsignifi cant correlations with satisfaction for those with AS.
As hypothesised, those who were work disabled because of their disease in both the AS and PsA groups reported lower satisfaction.
Finally, role importance was more highly associated with the satisfaction subscales for older people than for younger people for both the AS and PsA participants. For participants with PsA the correlation of importance with time spent and role performance was small and not signifi cant in those aged <40 years. However, the magnitude of the correlation increased with age (50-59 years: range 0.40-0.50; ≥60 years: 0.70-0.75). For participants with AS, there was no signifi cant association for those aged 19-39 years and, for those 40-49 years, the correlations were 0.49 and 0.68 for importance with satisfaction with time spent and role performance, respectively.
DISCUSSION
This work shows that social role participation is an important concept for people with SpA and that the SRPQ is a reliable and valid measure for people with AS and PsA. The SRPQ incorporates the subjective aspects of participation, specifi cally an individual's desires and satisfaction. 14 This is in contrast to other measures of participation 26 that evaluate performance through frequency, limitation or role occupancy. 
The content validity of the SRPQ was supported by the cognitive debriefi ng process in this research, as well as by work of others evaluating individual aspects of participation. Ward et al found that family life and participation in the labour force were affected in people with AS. 5 Additionally, people with AS were more likely never to marry and, if married, were less likely to have children and more likely to be divorced. Boonen et al also reported work disability in people with AS 3 4 and Wallenius et al reported work disability in people with PsA aged 19-40 years. 6 Finally, the domains included in the SRPQ refl ect common problems experienced by people with AS 19 and PsA. 21 The SRPQ items represent concepts of social roles (eg, physical leisure) rather then specifi c pursuits within a role (eg, gardening). Although there is diversity in the range of roles captured, the inter-item correlations and internal consistency showed that each of the satisfaction subscales (satisfaction with time spent in roles and satisfaction with role performance) represented a unifi ed concept. The importance ratings demonstrated lower internal consistency than the satisfaction ratings. We interpret the variability in response and lower internal consistency to refl ect the different choices and preferences people have for the many social roles in which they participate. Work that describes obligatory and discretionary activities and roles supports our interpretation. 14 43 44 The test-retest reliability levels of the SRPQ subscales are suffi cient for groups and individuals (ie, >0.90), with the exception of the importance subscale for PsA. 38 Evaluation of construct validity was guided by fi ndings from the existing literature, recognising that most authors evaluated a specifi c aspect of participation. With few exceptions, we were able to confi rm our hypotheses. The LLDI 26 and KAP 24 include a number of items that are more task-orientated and they had moderate correlations (0.40-0.70) with the SRPQ satisfaction subscales. The exception was in AS where the correlations were 0.76 and 0.78. While these relationships were slightly higher than expected, only about 60% of the variance in satisfaction is explained. Our fi ndings that more disease severity and activity, psychological impact and functional limitations were associated with less satisfaction in participation similarly is supported by the literature. 17 45 -47 For example, in people with AS, Healey et al found that poor function, depression, increased disease activity, unemployment and poor self-effi cacy were independently associated with more problems in sexual relationships. 45 In people with SpA, Da Costa et al found that mental health status and leisure time activity were associated with fatigue and that mental health moderated the relationship between leisure time activity and fatigue-that is, leisure activity was associated with decreased fatigue in those with good mental health. 46 Similar to our fi ndings that older people were most satisfi ed with their participation in social roles, Healey et al found that younger people with AS (18-49 years) reported a greater impact on their relationships than those aged ≥65 years. 45 Dagfi nrud et al similarly found that the impact of AS decreased with age. 48 Work disability has been reported in AS and PsA 3 -5 and, although the number not working because of their disease was small, we found that, as hypothesised, those who were work disabled were less satisfi ed with their participation.
Most surprising was the fi nding that back pain in people with AS was not signifi cantly associated with any of the SRPQ subscales. We anticipated that these correlations would be modest given other literature that suggests that pain is moderately associated with physical disability and that disability mediates the relationship between pain and participation. 47 The correlations with the satisfaction subscales were −0.l9 and −0.22. However, as our sample included only 44 participants with AS, our fi ndings may refl ect a β error. 49 This work includes a clinical sample from a single institution which may limit its generalisability. However, the participants with AS and PsA are comparable to those reported in the literature based on demographics, disease severity and disability. The PsA group included a slightly higher proportion of men. In addition, as the questionnaires required fl uency in English, cultural differences may not have been captured. The SRPQ, as with other participation measures, has been developed in English and there may be interesting differences in perceived role importance and participation in relation to culture. Furthermore, while the content of the measure was developed from several sources 17 and confi rmed in the current participants, future work prior to use in other countries should confi rm that the content is relevant and that there are no omissions.
In summary, the SRPQ is a reliable and valid measure of social role participation in people with SpA that can be used to evaluate the complex inter-relationships of symptoms, disability and participation, and the personal and environmental contextual factors that infl uence participation itself and these relationships. Longitudinal studies will enhance our understanding of the impact of disease on participation over the life course as people evolve their social roles. Finally, further research needs to evaluate the responsiveness of the SRPQ subscales in response to interventions so that we can further understand their impact on people's participation.
